# CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
> **ANDA212266** · Abbreviated New Drug Application (Generic) · Sponsor: QUAGEN · Approved 2019-05-16
## Drug
- **FDA Application Number:** ANDA212266
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
- **Generic name:** CETIRIZINE HYDROCHLORIDE
- **Active ingredients:** CETIRIZINE HYDROCHLORIDE
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Over-the-counter
- **Sponsor:** QUAGEN
- **Manufacturer:** QUAGEN PHARMACEUTICALS LLC
- **First approval:** 2019-05-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212266)
---
*MORVS · CC0 1.0*